Austria’s Apeiron To Attack COVID-19 At Its Entry Point

Phase II Study Starts In Three European Countries

 
• By John Davis
  
Peter Llewellyn-Davies
Apeiron Biologics CEO Peter Llewellyn-Davies • Source: Apeiron Biologics
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip